A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)

Clinical trial NCT07492303 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07492303
Sponsor: Changchun BCHT Biotechnology Co.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pertussis (Whooping Cough)Diphtheria Tetanus

Start date: 2026-04-20
Primary completion: 2026-07-10
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.